BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iordache AM, Buga AM, Albulescu D, Vasile RC, Mitrut R, Georgiadis G, Zisis IE, Mamoulakis C, Tsatsakis A, Docea AO, Calina D. Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy. Food Chem Toxicol 2020;143:111535. [PMID: 32622850 DOI: 10.1016/j.fct.2020.111535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zisis I, Georgiadis G, Docea AO, Calina D, Cercelaru L, Tsiaoussis I, Lazopoulos G, Sofikitis N, Tsatsakis A, Mamoulakis C. Renoprotective Effect of Vardenafil and Avanafil in Contrast-Induced Nephropathy: Emerging Evidence from an Animal Model. JPM 2022;12:670. [DOI: 10.3390/jpm12050670] [Reference Citation Analysis]
2 Taheri Y, Quispe C, Herrera-Bravo J, Sharifi-Rad J, Ezzat SM, Merghany RM, Shaheen S, Azmi L, Prakash Mishra A, Sener B, Kılıç M, Sen S, Acharya K, Nasiri A, Cruz-Martins N, Tsouh Fokou PV, Ydyrys A, Bassygarayev Z, Daştan SD, Alshehri MM, Calina D, Cho WC. Urtica dioica-Derived Phytochemicals for Pharmacological and Therapeutic Applications. Evid Based Complement Alternat Med 2022;2022:4024331. [PMID: 35251206 DOI: 10.1155/2022/4024331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
3 Tsoukalas D, Buga AM, Docea AO, Sarandi E, Mitrut R, Renieri E, Spandidos DA, Rogoveanu I, Cercelaru L, Niculescu M, Tsatsakis A, Calina D. Reversal of brain aging by targeting telomerase: A nutraceutical approach. Int J Mol Med 2021;48:199. [PMID: 34515324 DOI: 10.3892/ijmm.2021.5032] [Reference Citation Analysis]
4 Kusirisin P, Chattipakorn SC, Chattipakorn N. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J Transl Med 2020;18:400. [PMID: 33081797 DOI: 10.1186/s12967-020-02574-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Nio Y, Ookawara M, Yamasaki M, Hanauer G, Tohyama K, Shibata S, Sano T, Shimizu F, Anayama H, Hazama M, Matsuo T. Ameliorative effect of phosphodiesterase 4 and 5 inhibitors in deoxycorticosterone acetate-salt hypertensive uni-nephrectomized KKAy mice. FASEB J 2020;34:14997-5014. [PMID: 32939821 DOI: 10.1096/fj.202001084R] [Reference Citation Analysis]
6 Sarkar C, Mondal M, Torequl Islam M, Martorell M, Docea AO, Maroyi A, Sharifi-Rad J, Calina D. Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives. Front Pharmacol 2020;11:572870. [PMID: 33041814 DOI: 10.3389/fphar.2020.572870] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
7 Zhang F, Lu Z, Wang F. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci 2020;259:118379. [PMID: 32890604 DOI: 10.1016/j.lfs.2020.118379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Musiał K, Augustynowicz M, Miśkiewicz-Migoń I, Kałwak K, Ussowicz M, Zwolińska D. Clusterin as a New Marker of Kidney Injury in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation-A Pilot Study. J Clin Med 2020;9:E2599. [PMID: 32796610 DOI: 10.3390/jcm9082599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]